Optimisation of the tumour response threshold in patients treated with everolimus for metastatic renal cell carcinoma: analysis of response and progression-free survival in the RECORD-1 study.
about
Are we ready for the 10% solution?Dynamic tumor modeling of the dose-response relationship for everolimus in metastatic renal cell carcinoma using data from the phase 3 RECORD-1 trial.Treatment outcome with mTOR inhibitors for metastatic renal cell carcinoma with nonclear and sarcomatoid histologies.Imaging techniques as predictive and prognostic biomarkers in renal cell carcinoma.Molecular Targeted Therapy in Modern Oncology: Imaging Assessment of Treatment Response and Toxicities.Heterogeneous drug target expression as possible basis for different clinical and radiological response to the treatment of primary and metastatic renal cell carcinoma: suggestions from bench to bedside.Recommendations for the clinical and radiological evaluation of response to treatment in metastatic renal cell cancer.Prognostic factors in patients with advanced renal cell carcinoma treated with VEGF-targeted agents.Future perspectives for mTOR inhibitors in renal cell cancer treatment.mTOR-inhibitor treatment of metastatic renal cell carcinoma: contribution of Choi and modified Choi criteria assessed in 2D or 3D to evaluate tumor response.Imaging Response of Antiangiogenic and Immune-Oncology Drugs in Metastatic Renal Cell Carcinoma (mRCC): Current Status and Future Challenges
P2860
Q33577894-7E5A8CFC-238E-4D6C-BFA5-5D7124EE997FQ34348318-92C66241-FEF1-4140-A224-2FC04D84C7B4Q34500828-09BEEBDA-8B49-4513-9656-B17AD304AB0EQ36567385-364564B9-5B41-44AD-A271-3CB509EEF02EQ37589551-C540E64E-6DA7-4CE0-9B86-3252CC6CC826Q38171327-258746ED-C232-4282-A70A-48D1BBD8238EQ38171376-24BF4400-F1E2-445F-9136-51B92F304CF9Q38196855-3B984351-EA7A-43B9-9EDD-1614E5EC1492Q38372445-9C6360D3-EEDD-4778-92AD-8ACE4DA360A5Q41754200-DB393377-5CA1-4F8E-89A3-8ECB629E7BE1Q58585071-0CC7BA60-0ADD-4B46-8C93-AAB8FD14F740
P2860
Optimisation of the tumour response threshold in patients treated with everolimus for metastatic renal cell carcinoma: analysis of response and progression-free survival in the RECORD-1 study.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Optimisation of the tumour res ...... urvival in the RECORD-1 study.
@en
type
label
Optimisation of the tumour res ...... urvival in the RECORD-1 study.
@en
prefLabel
Optimisation of the tumour res ...... urvival in the RECORD-1 study.
@en
P2093
P50
P1476
Optimisation of the tumour res ...... survival in the RECORD-1 study
@en
P2093
Ashok Panneerselvam
Dennis Kim
Elizabeth Fabre
Euloge Kpamegan
Florian Scotte
Jacques Medioni
Rokhaya Thiam
Stéphane Oudard
P304
P356
10.1016/J.EJCA.2012.01.027
P577
2012-02-16T00:00:00Z